Morgan Stanley’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$155K Buy
212,015
+9,067
+4% +$6.63K ﹤0.01% 5953
2025
Q1
$164K Sell
202,948
-1,908,354
-90% -$1.54M ﹤0.01% 5819
2024
Q4
$2.91M Buy
2,111,302
+1,284,325
+155% +$1.77M ﹤0.01% 4427
2024
Q3
$860K Sell
826,977
-729,873
-47% -$759K ﹤0.01% 5128
2024
Q2
$2.69M Sell
1,556,850
-1,107,319
-42% -$1.92M ﹤0.01% 4358
2024
Q1
$6.37M Sell
2,664,169
-1,475,537
-36% -$3.53M ﹤0.01% 3719
2023
Q4
$13.8M Buy
4,139,706
+897,479
+28% +$2.99M ﹤0.01% 3660
2023
Q3
$12.1M Buy
3,242,227
+227,107
+8% +$849K ﹤0.01% 2942
2023
Q2
$12.9M Buy
3,015,120
+2,505,776
+492% +$10.7M ﹤0.01% 2923
2023
Q1
$3.48M Sell
509,344
-204,647
-29% -$1.4M ﹤0.01% 4077
2022
Q4
$5.65M Buy
713,991
+12,963
+2% +$103K ﹤0.01% 3644
2022
Q3
$6.74M Sell
701,028
-112,108
-14% -$1.08M ﹤0.01% 3392
2022
Q2
$5.89M Buy
813,136
+227,083
+39% +$1.64M ﹤0.01% 3609
2022
Q1
$7.57M Buy
586,053
+182,755
+45% +$2.36M ﹤0.01% 3235
2021
Q4
$6.44M Sell
403,298
-27,466
-6% -$438K ﹤0.01% 3453
2021
Q3
$6.92M Sell
430,764
-194,036
-31% -$3.12M ﹤0.01% 3336
2021
Q2
$8.64M Sell
624,800
-61,851
-9% -$856K ﹤0.01% 3153
2021
Q1
$10M Buy
686,651
+110,457
+19% +$1.61M ﹤0.01% 2647
2020
Q4
$10M Buy
576,194
+327,780
+132% +$5.7M ﹤0.01% 2506
2020
Q3
$4.56M Buy
248,414
+20,801
+9% +$382K ﹤0.01% 2801
2020
Q2
$4.07M Buy
227,613
+201,577
+774% +$3.6M ﹤0.01% 2881
2020
Q1
$422K Sell
26,036
-222,861
-90% -$3.61M ﹤0.01% 4473
2019
Q4
$4.48M Buy
248,897
+115,535
+87% +$2.08M ﹤0.01% 3311
2019
Q3
$2.7M Buy
133,362
+75,475
+130% +$1.53M ﹤0.01% 3519
2019
Q2
$1.28M Buy
57,887
+16,038
+38% +$354K ﹤0.01% 4089
2019
Q1
$570K Sell
41,849
-41,329
-50% -$563K ﹤0.01% 4474
2018
Q4
$753K Sell
83,178
-17,939
-18% -$162K ﹤0.01% 4498
2018
Q3
$1.67M Sell
101,117
-193,326
-66% -$3.19M ﹤0.01% 4153
2018
Q2
$4.12M Buy
294,443
+99,324
+51% +$1.39M ﹤0.01% 3370
2018
Q1
$2.16M Buy
195,119
+110,239
+130% +$1.22M ﹤0.01% 3941
2017
Q4
$747K Buy
84,880
+28,279
+50% +$249K ﹤0.01% 4745
2017
Q3
$756K Sell
56,601
-4,268
-7% -$57K ﹤0.01% 4612
2017
Q2
$874K Buy
60,869
+1,026
+2% +$14.7K ﹤0.01% 4471
2017
Q1
$1.27M Sell
59,843
-86,306
-59% -$1.82M ﹤0.01% 4197
2016
Q4
$4.11M Buy
146,149
+89,276
+157% +$2.51M ﹤0.01% 3202
2016
Q3
$1.52M Buy
56,873
+54,941
+2,844% +$1.47M ﹤0.01% 3726
2016
Q2
$33K Sell
1,932
-33,365
-95% -$570K ﹤0.01% 5674
2016
Q1
$750K Buy
35,297
+31,690
+879% +$673K ﹤0.01% 4172
2015
Q4
$83K Sell
3,607
-11,880
-77% -$273K ﹤0.01% 5503
2015
Q3
$310K Buy
15,487
+5,952
+62% +$119K ﹤0.01% 4869
2015
Q2
$276K Buy
9,535
+8,568
+886% +$248K ﹤0.01% 5088
2015
Q1
$30K Sell
967
-57,806
-98% -$1.79M ﹤0.01% 5953
2014
Q4
$959K Buy
+58,773
New +$959K ﹤0.01% 4183